Vanessa Alves Marques
Overview
Explore the profile of Vanessa Alves Marques including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
84
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lago B, Portilho M, Mello V, De Sousa P, Angelice G, Marques B, et al.
Sci Rep
. 2024 May;
14(1):10742.
PMID: 38730249
The selection pressure imposed by the host immune system impacts on hepatitis B virus (HBV) variability. This study evaluates HBV genetic diversity, nucleos(t)ide analogs resistance and HBsAg escape mutations in...
2.
Portilho M, Bezerra C, Mendonca A, Marques V, Cancella Nabuco L, Villela-Nogueira C, et al.
Arch Virol
. 2021 Jun;
166(9):2435-2442.
PMID: 34146173
Little is known about the usefulness of saliva samples for hepatitis B virus (HBV) genotyping and mutation analysis. The aim of this study was to evaluate the usefulness of oral...
3.
de Paula V, Milagres F, Oliveira G, Miguel J, Cruz H, Scalioni L, et al.
BMC Res Notes
. 2020 Sep;
13(1):458.
PMID: 32993814
Objectives: Little is known about hepatitis A virus (HAV) prevalence in indigenous communities. This study aims to evaluate the prevalence of HAV in indigenous community compared to urban population located...
4.
Villar L, Costa V, Marques B, da Silva L, Santos A, Mendonca A, et al.
J Infect
. 2020 Jul;
82(1):e4-e5.
PMID: 32711040
No abstract available.
5.
Villar L, de Paula V, do Lago B, Miguel J, Cruz H, Portilho M, et al.
Arch Virol
. 2020 Feb;
165(4):913-922.
PMID: 32078045
Methods: A total of 622 individuals were included; the mean age was 36.6 ± 14.3 years and 55.4% were females. HBV and HCV markers were detected using serological and molecular...
6.
Villar L, Geloneze B, Vasques A, Pires M, Miguel J, Silva E, et al.
PLoS One
. 2019 Mar;
14(2):e0211193.
PMID: 30817756
Diabetes mellitus type 2 (DM2) patients have higher risk to be infected with parenterally transmitted viruses, like hepatitis B or C virus. This study aims to determine HBV and HCV...
7.
Cruz H, Cruz J, Silva E, Portilho M, Marques V, Lewis-Ximenez L, et al.
J Immunoassay Immunochem
. 2018 May;
39(2):228-233.
PMID: 29733758
Dried blood spots (DBSs) could be an alternative to serum for hepatitis B virus (HBV) and hepatitis C virus (HCV) diagnosis. This study aims to evaluate two enzyme immunoassays (EIAs)...
8.
Performance of point of care assays for hepatitis B and C viruses in chronic kidney disease patients
Barbosa J, Cortes V, Portilho M, Miguel J, Marques V, Bezerra C, et al.
J Clin Pathol
. 2018 May;
71(10):879-884.
PMID: 29730611
Aims: Point of care testing (POCT) has been used for hepatitis B and C diagnosis in general population, but little is known about the influence of clinical conditions in the...
9.
Villar L, Caldas G, Scalioni L, Miguel J, Silva E, Marques V, et al.
Arch Endocrinol Metab
. 2018 Feb;
61(6):628-632.
PMID: 29412389
Objective: This study aims to estimate the prevalence of insulin resistance (IR) among chronic hepatitis C (CHC) patients and their related laboratory and demographic data. Subjects And Methods: In this...
10.
Barbosa J, Colares J, Flores G, Cortes V, Miguel J, Portilho M, et al.
J Virol Methods
. 2017 Aug;
248:244-249.
PMID: 28782578
There is little information describing the influence of HIV infection upon the performance of rapid diagnostic tests (RDTs) for hepatitis B and C virus diagnosis. This study aims to evaluate...